Stay informed with the latest litigation news. Explore now

IP Verse

Ares Trading competitive analysis

Latest publications and patents of Ares Trading New

Explore the latest publications and patents granted to Ares Trading, showcasing their recent innovations and technological advancements.

Last updated on: Sep 11, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Ares Trading

EP2061803
Nov 16, 2022Process For The Purification Of Fc-Containing ProteinsPatent Maintained As Amended
EP2827150
Aug 18, 2021Imaging And Evaluating Embryos, Oocytes, And Stem CellsThe Patent Has Been Limited
EP3145488
Jul 22, 2020Liquid Pharmaceutical CompositionOpposition Rejected
EP3061013
Apr 22, 2020Patient Care System Reporting Adherence To Treatment RegimenRevoked
EP2854790
Aug 29, 2018Use Of N-Acetyl-5-Methoxytryptamine Or Analogues Thereof, For Promoting The Mechanism Of Implantation Of The Embryo And Related Compositions And Culture MediaRevoked
EP3145487
Aug 22, 2018Liquid Pharmaceutical CompositionGranted And Under Opposition
EP3148510
Jun 27, 2018Liquid Pharmaceutical CompositionRevoked
EP2713517
Jan 3, 2018Injection Device With A Capacitive Proximity SensorNo Opposition Filed Within Time Limit
EP2753634
Nov 1, 2017Method For Preparing Active Form Of Tnfr-Fc Fusion ProteinGranted And Under Opposition

Latest oppositions filed by Ares Trading

Explore patent oppositions filed by Ares Trading against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 18, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP3021869
Methods Of Treating Cancer Using Pd-1 Axis Binding Antagonists And Tigit InhibitorsF HOFFMANN LA ROCHEApr 15, 2021
EP3144318
Recombinant Fsh Including Alpha 2,3- And Alpha 2,6-SialylationFERRINGMar 25, 2021
EP3303632
Therapeutic And Diagnostic Methods For CancerF HOFFMANN LA ROCHEDec 4, 2020
EP3083686
Methods Of Treating Cancers Using Pd-1 Axis Binding Antagonists And TaxanesF HOFFMANN LA ROCHEJul 23, 2020
EP2542590
Compositions And Methods For Targeted Immunomodulatory Antibodies And Fusion ProteinsTHE JOHNS HOPKINS UNIVERSITYFeb 2, 2018

Latest patents of Ares Trading opposed by its competitors

Explore Ares Trading's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 18, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP2061803
Nov 16, 2022Process For The Purification Of Fc-Containing Proteins2
EP2827150
Aug 18, 2021Imaging And Evaluating Embryos, Oocytes, And Stem Cells1
EP3145488
Jul 22, 2020Liquid Pharmaceutical Composition3
EP3061013
Apr 22, 2020Patient Care System Reporting Adherence To Treatment Regimen1
EP2854790
Aug 29, 2018Use Of N-Acetyl-5-Methoxytryptamine Or Analogues Thereof, For Promoting The Mechanism Of Implantation Of The Embryo And Related Compositions And Culture Media1
EP3145487
Aug 22, 2018Liquid Pharmaceutical Composition1
EP3148510
Jun 27, 2018Liquid Pharmaceutical Composition2
EP2753634
Nov 1, 2017Method For Preparing Active Form Of Tnfr-Fc Fusion Protein1

Latest PTAB cases involving Ares Trading New

Discover the latest PTAB cases involving Ares Trading, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 17, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Ares Trading

IPR2023-00482Feb 10, 2023HOPEWELL PHARMA VENTURESARES TRADINGTerminated-Settled

Top competitors of Ares Trading

Top competitors of Ares Trading based on patent oppositions.